Latest Prescription Drugs news
GLP-1 Receptor Agonists Tied to Reduced Mortality in Patients With Psoriasis
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Elinzanetant Safe, Effective for Moderate-to-Severe Vasomotor Symptoms
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Inluriyo for Advanced Breast Cancer
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Opzelura for Atopic Dermatitis in Children
posted September 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Frequent Cannabis Use Linked to Epilepsy Severity Monthly Specialist Briefings
Stay Connected
